Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BBY vs GSK✓SelectedUSD · GSKBBY vs GSK performance historyLatest closeAs of+1.94%11/18
Stock and ETF performance explorer

BBY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+81,492.2%
GSK return
+1,674.3%
Excess return
+79,817.9%
Maximum drawdown
-80.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.9%-1.3%+3.3%+2.4%
7D-4.6%-3.1%-1.5%-3.5%
30D+10.1%-0.9%+11.0%+10.5%
3M+16.1%-4.2%+20.3%+18.0%
6M+77.5%-1.6%+79.0%+77.9%
YTD+55.8%+2.6%+53.2%+53.1%
1Y+42.0%+6.2%+35.8%+37.7%
3Y+70.2%+55.0%+15.2%+40.1%
5Y-6.6%+42.8%-49.4%-22.3%
10Y+222.1%+102.1%+120.0%+132.1%
All+81,492.2%+1,674.3%+79,817.9%+28,765.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling